Geron (GERN) Other Operating Expenses (2010 - 2026)
Geron's (GERN) quarterly Other Operating Expenses came in at $9.2 million in Q2 2026, up 676.47% year-over-year from $1.2 million in Q2 2025, and up 446.1% quarter-over-quarter from $1.7 million in Q1 2026.
Analysis
Geron (GERN) Other Operating Expenses (2010 - 2026) Analysis & Trends
Geron has disclosed Other Operating Expenses across 7 years of filings, most recently posting $9.2 million for Q2 2026.
- In Q2 2026, Other Operating Expenses rose 676.47% year-over-year to $9.2 million; the TTM figure through Jun 2026 stood at $30.3 million (up 733.92% YoY), while the FY2025 annual figure was $4.7 million, up 277.79% from the prior year.
- Other Operating Expenses came in at $9.2 million for Q2 2026 at Geron, up from $1.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $18.3 million in Q4 2025 to a low of $17000.0 in Q2 2024.
- Average Other Operating Expenses over 3 years is $3.8 million, with a median of $1.2 million recorded in 2025.
- Year-over-year, Other Operating Expenses surged 6900.0% in 2025 and soared 40.3% in 2026.
- Over 3 years, Other Operating Expenses stood at $783000.0 in 2024, then soared by 2242.02% to $18.3 million in 2025, then sank by 49.61% to $9.2 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $9.2 million in Q2 2026, $1.7 million in Q1 2026, and $18.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.24 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 18.34 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 783,000.00 |
| Sep 30, 2024 | 456,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Dec 31, 2018 | 1.46 Mn |
| Dec 31, 2013 | -194,000.00 |
| Sep 30, 2013 | -824,000.00 |
| Jun 30, 2013 | -1.96 Mn |
| Dec 31, 2011 | 5.45 Mn |
| Dec 31, 2010 | 35.00 Mn |